Vivian Huang
@yuhsinvhuang.bsky.social
MD/PhD Student at the Weill Cornell-Rockefeller-Memorial Sloan Kettering Tri-Institutional Program ◦ she/her
Reposted by Vivian Huang
Proud to share this new pub from my lab - “Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis” www.ahajournals.org/doi/10.1161/.... Congrats to first authors Vivian Huang and Yin Sun. Our first foray into targeted therapy for this devastating autoimmune condition
Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis | Circulation Research
BACKGROUND: Immune checkpoint inhibitors (ICIs) are successful in treating many cancers but may
cause immune-related adverse events. ICI-mediated myocarditis has a high fatality
rate with severe cardi...
www.ahajournals.org
February 11, 2025 at 12:05 PM
Proud to share this new pub from my lab - “Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis” www.ahajournals.org/doi/10.1161/.... Congrats to first authors Vivian Huang and Yin Sun. Our first foray into targeted therapy for this devastating autoimmune condition